Dr. Caroline Ingre

KAROLINSKA UNIVERSITY HOSPITAL, STOCKHOLM, SWEDEN

“I believe genetic testing across all ALS patients is critical to find those who have genetic ALS.”
Healthcare professionals are paid consultants for Biogen.

Dr. Christopher McDermott

SHEFFIELD INSTITUTE FOR TRANSLATIONAL NEUROSCIENCE, SHEFFIELD, ENGLAND

“There will be an explosion in information needs for people with ALS and their families, and thereby healthcare professionals and those supporting them.”
Healthcare professionals are paid consultants for Biogen.

Prof. Orla Hardiman

TRINITY COLLEGE DUBLIN, DUBLIN, IRELAND

"Focusing on genetics and being disciplined and collaborative is the way we move forward in ALS care."
Healthcare professionals are paid consultants for Biogen.

Dr. Caroline Ingre

KAROLINSKA UNIVERSITY HOSPITAL, STOCKHOLM, SWEDEN

“Genetic markers are a valuable way to differentiate what ALS could look like on an individual level.”
Healthcare professionals are paid consultants for Biogen.

DR. Philippe Corcia

UNIVERSITY OF TOURS REGIONAL HOSPITAL CENTER BRETONNEAU, TOURS, FRANCE

“We have always hoped that genetics would allow us to better understand ALS. Now we know it is possible.”
Healthcare professionals are paid consultants for Biogen.

PROF. ALBERT LUDOLPH

ACADEMIC NEUROSCIENCE CENTRE OF THE UNIVERSITY OF ULM, ULM, GERMANY

“Learning more about the relation between genetics and ALS is an avenue to better understanding ALS.”
Healthcare professionals are paid consultants for Biogen.

Dr. Caroline Ingre

KAROLINSKA UNIVERSITY HOSPITAL, STOCKHOLM, SWEDEN

“I think it's important to acknowledge that science is, in every sense, moving forward and we should embrace that and use that.”
Healthcare professionals are paid consultants for Biogen.

PROF. LEONARD VAN DEN BERG

UMC UTRECHT, UTRECHT, NETHERLANDS

“Research continues to expand our vision of ALS, quickly increasing what we can learn from genetics in ALS.”
Healthcare professionals are paid consultants for Biogen.

DR. LORNE ZINMAN

SUNNYBROOK RESEARCH INSTITUTE, TORONTO, ONTARIO

“Now we may be able to identify genetic mutations associated with the disease, and, not only that, we can perhaps enroll patients into a clinical trial.”
Healthcare professionals are paid consultants for Biogen.

More than 10% of all ALS cases are caused by genetic mutations.¹ insideALS brings you information on the science of genetic ALS.

What makes insideALS unique?

insideALS, created by Biogen in consultation with key medical experts and patient advocacy groups, gathers resources focused on genetic ALS to support patients living with ALS, their caregivers, and healthcare professionals.

Healthcare Professionals

If you are a US Healthcare professional and want to learn more about the evolving science of genetic ALS, please click below to continue to our HCP-only page.

Patients and Caregivers

If you are a US resident 18 years or older and a person living with ALS, caregiver of a person living with ALS, or would like to better understand genetic ALS, click below to learn more.

References

1. Roggenbuck J, Quick A, Kolb SJ. Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians. Genet Med. 2017;19(3):267-274.